Pryd y mae'r Gweinidog yn rhagweld y bydd pob claf canser cymwys yn cael prawf diagnosteg moleciwlau? Derbyniwyda ateb ar 18 Tachwedd 2016Vaughan Gething: Testing for a relatively small group of genes is currently available for patients with colorectal, lung, melanoma, breast and ovarian cancer solid tumours. A Welsh Government-led taskforce is developing a Genomics for Precision Medicine Strategy. This will identify the developments in genomics which are needed in Wales to underpin more accurate molecular diagnostic testing and better prediction of response to treatments. It will also propose key actions to support molecular diagnostic testing for a range of disease areas, including cancer, in line with the expected demand and benefits to patients. As such it is not possible to say when these tests and treatments will be available for every eligible cancer patients.
Testing for a relatively small group of genes is currently available for patients with colorectal, lung, melanoma, breast and ovarian cancer solid tumours.
A Welsh Government-led taskforce is developing a Genomics for Precision Medicine Strategy. This will identify the developments in genomics which are needed in Wales to underpin more accurate molecular diagnostic testing and better prediction of response to treatments. It will also propose key actions to support molecular diagnostic testing for a range of disease areas, including cancer, in line with the expected demand and benefits to patients. As such it is not possible to say when these tests and treatments will be available for every eligible cancer patients.